Back to Search Start Over

Swedish Nerve Growth Factor Mutation (NGF R100W ) Defines a Role for TrkA and p75 NTR in Nociception.

Authors :
Sung K
Ferrari LF
Yang W
Chung C
Zhao X
Gu Y
Lin S
Zhang K
Cui B
Pearn ML
Maloney MT
Mobley WC
Levine JD
Wu C
Source :
The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2018 Apr 04; Vol. 38 (14), pp. 3394-3413. Date of Electronic Publication: 2018 Feb 26.
Publication Year :
2018

Abstract

Nerve growth factor (NGF) exerts multiple functions on target neurons throughout development. The recent discovery of a point mutation leading to a change from arginine to tryptophan at residue 100 in the mature NGFβ sequence (NGF <superscript>R100W</superscript> ) in patients with hereditary sensory and autonomic neuropathy type V (HSAN V) made it possible to distinguish the signaling mechanisms that lead to two functionally different outcomes of NGF: trophic versus nociceptive. We performed extensive biochemical, cellular, and live-imaging experiments to examine the binding and signaling properties of NGF <superscript>R100W</superscript> Our results show that, similar to the wild-type NGF (wtNGF), the naturally occurring NGF <superscript>R100W</superscript> mutant was capable of binding to and activating the TrkA receptor and its downstream signaling pathways to support neuronal survival and differentiation. However, NGF <superscript>R100W</superscript> failed to bind and stimulate the 75 kDa neurotrophic factor receptor (p75 <superscript>NTR</superscript> )-mediated signaling cascades (i.e., the RhoA-Cofilin pathway). Intraplantar injection of NGF <superscript>R100W</superscript> into adult rats induced neither TrkA-mediated thermal nor mechanical acute hyperalgesia, but retained the ability to induce chronic hyperalgesia based on agonism for TrkA signaling. Together, our studies provide evidence that NGF <superscript>R100W</superscript> retains trophic support capability through TrkA and one aspect of its nociceptive signaling, but fails to engage p75 <superscript>NTR</superscript> signaling pathways. Our findings suggest that wtNGF acts via TrkA to regulate the delayed priming of nociceptive responses. The integration of both TrkA and p75 <superscript>NTR</superscript> signaling thus appears to regulate neuroplastic effects of NGF in peripheral nociception. SIGNIFICANCE STATEMENT In the present study, we characterized the naturally occurring nerve growth factor NGF <superscript>R100W</superscript> mutant that is associated with hereditary sensory and autonomic neuropathy type V. We have demonstrated for the first time that NGF <superscript>R100W</superscript> retains trophic support capability through TrkA, but fails to engage p75 <superscript>NTR</superscript> signaling pathways. Furthermore, after intraplantar injection into adult rats, NGF <superscript>R100W</superscript> induced neither thermal nor mechanical acute hyperalgesia, but retained the ability to induce chronic hyperalgesia. We have also provided evidence that the integration of both TrkA- and p75 <superscript>NTR</superscript> -mediated signaling appears to regulate neuroplastic effects of NGF in peripheral nociception. Our study with NGF <superscript>R100W</superscript> suggests that it is possible to uncouple trophic effect from nociceptive function, both induced by wild-type NGF.<br />Competing Interests: The authors declare no competing financial interests.<br /> (Copyright © 2018 the authors 0270-6474/18/383395-20$15.00/0.)

Details

Language :
English
ISSN :
1529-2401
Volume :
38
Issue :
14
Database :
MEDLINE
Journal :
The Journal of neuroscience : the official journal of the Society for Neuroscience
Publication Type :
Academic Journal
Accession number :
29483280
Full Text :
https://doi.org/10.1523/JNEUROSCI.1686-17.2018